Mangaluru all set to host co-existence conference

Belagavi, Apr 19: Veteran writer and Translator Chandrakanth Kusnoor passed away in his house on Sunday due to age-related disease.

He was 90.

He was survived by wife, four sons and one daughter.

According to family sources, the last rites were held in the wee hours of Sunday.

Mr Kushnoor, a multi-faceted personality, maybe the one of the few who had won the Karnataka Nataka Academy, Karnataka Lalitha Kala Academy and Karnataka Sahitya Academy awards for his works as writer, translator, novelist, poet, playwright, painter, art critic and institution builder.

He had translated many books from Kannada (late U R Ananthmurthy and Srikrishna Alanahalli) into Hindi, and other books into Marathi and Urdu.

He was among the pioneering abstract writers in Kannada. His plays like Dindi, Vidushaka, Ratto Ratto Rayara Magale and Ani Bantu Ondu Ani, were widely performed.

His biographical novel Gohar Jan chronicles the growth of professional theatre music tradition.

He had converted his home in Channamma Nagar into a mini art gallery and used to paint till recently. He hailed from Kalaburagi where he worked as a college professor for some years. He had settled in Belagavi after his retirement as the Deputy Director of Kannada and culture.

He had won the Karnataka Rajyotsava Award.

New Delhi, Mar 19: The Supreme Court on Thursday upheld the validity of Karnataka's 2018 reservation law, which granted reservation in promotion to employees belonging to SC and ST categories.

A bench headed by Justice DY Chandrachud holds that applications filed by a group of general category employees for applying 'post-based quota' and the principle of the creamy layer at entry-level in public employment are not maintainable.

The apex court had, in November last year, reserved its order on the applications filed by general category candidates in the matter.

In May last year, the top court had upheld the law allowing reservations in promotions for SC and ST candidates with consequential seniority.

French Nobel prize winning scientist Luc Montagnier has sparked a fresh controversy by claiming that the SARS-CoV-2 virus came from a lab, and is the result of an attempt to manufacture a vaccine against the AIDS virus.

In an interview given to French CNews channel and during a podcast by Pourquoi Docteur, professor Montagnier who co-discovered HIV (Human Immunodeficiency Virus) claimed the presence of elements of HIV in the genome of the coronavirus and even elements of the "germ of malaria" are highly suspect, according to a report in Asia Times.

"The Wuhan city laboratory has specialized in these coronaviruses since the early 2000s. They have expertise in this area," he was quoted as saying.

The theory that Covid-19 virus originated in the lab is making rounds for quite some time.

US President Donald Trump last week acknowledged Fox News report that the novel coronavirus may have been accidentally leaked by an intern working at the Wuhan Institute of Virology in China.

The Fox News, in an exclusive report, based on unnamed sources has claimed that though the virus is a naturally occurring strain among bats and not a bioweapon, but it was being studied in Wuhan laboratory.

The initial transmission of the virus was bat-to-human, the news channel said, adding that the "patient zero" worked at the laboratory. The lab employee was accidentally infected before spreading the disease among the common people outside the lab in Wuhan city.

Professor Montagnier was awarded the 2008 Nobel Prize in Medicine for the identification of AIDS virus, with his colleague professor Franeoise Barre-Sinoussi.

His fresh claim on coronavirus, however, received criticism from scientists, including his colleagues.

"Just in case you don't know. Dr Montagnier has been rolling downhill incredibly fast in the last few years. From baselessly defending homeopathy to becoming an antivaxxer. Whatever he says, just don't believe him," tweeted Juan Carlos Gabaldon.

As per a recent Washington Post, two years ago, the US embassy officials in China raised concerns about the insufficient biosafety at the Chinese government's Wuhan Institute of Virology where deadly viruses and infectious diseases are studied.

Though the institute, located quite close to the Wuhan wet market, is China's first biosafety level IV lab, the US state department had warned in 2018 about "serious shortage of appropriately trained technicians and investigators needed to safely operate this high-containment laboratory".